Clinical Trials Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy 12 Jan 2021
Avelas doses first patient in Period 2 of AVB-620 study Avelas Biosciences has dosed the first patient in the Period 2 of a Phase ll... 3rd August 2018
Clinical Research Reify Health extends StudyTeam platform availability for clinical trials 21 Jan 2021